Health research ethics in public health: Trials and implementation of malaria mosquito control strategies

Acta Tropica

Volumn 112, Issue SUPPL. 1, 2009, Pages

  Kilama, Wen L ^a  

^a African Malaria Network Trust   (Tanzania)

Author keywords

Africa; Health research ethics; Malaria vector control; Public health

Indexed keywords

ARTEMISININ; CHLOROQUINE; CHLORPHENOTANE; FANSIDAR; INSECTICIDE;

DISEASE CONTROL; ETHICS; GUIDELINE; IMPLEMENTATION PROCESS; MALARIA; PUBLIC HEALTH;

AFRICA; ARTICLE; BED NET; BIOETHICS; BIOLOGICAL PEST CONTROL; CONTROL STRATEGY; ENTOMOPATHOGENIC FUNGUS; HEALTH CARE PLANNING; HUMAN; INFORMED CONSENT; INSTRUMENT STERILIZATION; JUSTICE; MALARIA; MALARIA CONTROL; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; RESEARCH ETHICS; RISK BENEFIT ANALYSIS; TRANSGENIC ORGANISM; VECTOR CONTROL;

AFRICA; ANIMALS; BIOMEDICAL RESEARCH; ETHICS, RESEARCH; HUMANS; INFORMED CONSENT; MALARIA; MOSQUITO CONTROL; PEST CONTROL, BIOLOGICAL; PUBLIC HEALTH; SOCIAL JUSTICE;

AFRICA;

FUNGI;

EID: 70349141327     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.08.003     Document Type: Article

References (52)

1. Alifrangis M., Lemnge M.M., Ron A., et al. Increasing prevalence of wildtype in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of bed nets. Am. J. Trop. Med. Hyg. 69 3 (2003) 238-243
2. Anon. Oh New Delhi, Oh Geneva. Nature 256 (1975) 355-357 (editorial)
3. Anon. WHO-collaborative research projects in India: the facts. WHO Chron. 30 (1976) 131-139
4. Attaran A., Roberts D.R., Curtis C.F., and Kilama W.L. Balancing risks on the backs of the poor. Nat. Med. 6 7 (2000) 729-731
5. Beauchamp T.L., and Childress J.F. Principles of Biomedical Ethics. 5th edition (2001), Oxford University Press
6. Berg, H.V.D., 2009. Global Status of DDT and its Alternatives for Use in Vector Control and to Prevent Disease. National Institute of Environmental Health Sciences, National Institutes of Health, USDHHS. Available online at: http://dx.doi.org/, doi:10.1289/ehp.0900785 on 25 July 2009.
7. Berndtson K., Daid T., Tracy C.S., Bhan A., Cohen E.R.M., et al. Grand challenges in global health: ethical, social, and cultural issues based on key informant perspectives. PLoS Med. 4 September (9) (2007) e268 10.1371/journal.pmed.0040268
8. Bhan A., Jerome A., Singh R., Upshur E.G., et al. Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries. PLoS Med. 4 9 (2007) e272. www.plosmedicine.org
9. Bhutta Z.A. Ethics in international health research: a perspective from the developing world. Bull. WHO 80 2 (2002) 114-120
10. Carson R. Silent Spring (1962), Mariner Books Edition 2002, New York
11. Chandre F., Darrier F., Manga L., Akogbeto M., Faye O., Mouchet J., and Guillet P. Status of pyrethroid resistance in Anopheles gambiae sensu lato. Bull. WHO 77 3 (1999) 230-234
12. Chaoyang L., Mauro T., Marrelli G.Y., and Marcelo J.L. Fitness of transgenic Anopheles stephensi mosquitoes expressing the SM1 peptide under the control of a vitellogenin promoter. J. Hered. 99 3 (2008) 275-282
13. Council for International Organizations of Medical Sciences (CIOMS). International Guidelines for Ethical Review of Epidemiological Studies, Geneva (1991), CIOMS
14. Council for International Organizations of Medical Sciences (CIOMS). International Ethical Guidelines for Biomedical Research Involving Human Subjects, Geneva (2002), CIOMS pp. 112
15. Council for International Organizations of Medical Sciences (CIOMS). International Ethical Guidelines for Epidemiological Studies, Geneva (2008), CIOMS pp. 102
16. Curtis C.F., et al. Destruction in the 1970s of a research unit in India on genetic control of mosquitoes and a warning for the future management of transgenic research. Antenna 31 (2007) 214-216
17. Darriet F., N'guessan R., Koffi A.A., Konan L., Doannio J.M., Chandre F., and Carnevale P. Impact of pyrethroid resistance on the efficacy of impregnated mosquito nets in the prevention of malaria: results of tests in experimental cases with deltamethrin SC. Abstract PubMed (2000)
18. Declan B. Malaria drug makers ignore WHO ban. Nat. News 460 (2009) 310-311 10.1038/460310b (published online 14 July 2009)
19. Edwards J.G. A case study in scientific fraud. J. Am. Phys. Surg. 9 3 (2004) 83-88
20. Etang J., Chandre F., Guillet P., and Manga L. Reduced bio-efficacy of permethrin EC impregnated bednets against an Anopheles gambiae strain with oxidase-based pyrethroid tolerance. Malaria J. 3 46 (2004) 27 10.1186/1475-2875-3-46
21. Hargreaves K., Koekemoer L.L., Brooke B.D., Hunt R.H., Mthembu J., and Coetzee M. Med. Vet. Entomol. 14 2 (2000) 181-189
22. ICH Guideline for Good Clinical Practice, 1996. Available freely on many websites and other sources.
23. Kenya National Council for Science, and Technology. Guidelines for Ethical Conduct of Biomedical Research Involving Human Subjects in Kenya (2004), NCST No. 45, Nairobi 19 pp.
24. Knols B.G.J., Hood-Nowotny R.C., Bossin H., et al. GM sterile mosquitoes-a cautionary note. Nat. Biotechnol. 24 9 (2006) 1067-1068
25. Knols B.G.J., et al. Transgenic Mosquitoes and the fight against malaria: managing technology push in a turbulent GMO world. Am. J. Trop. Med. Hyg. 77 Suppl. 6 (2007) 232-242
26. Kouznetsov R.L. Malaria control by application of indoor spraying of residual insecticides in tropical Africa and its impact on community health. Trop. Doctor 7 (1977) 81-93
27. Lang T., Chilengi R., Noor R.A., Ogutu B., Todd J.E., Kilama W.L., and Targett G.A. Data safety and monitoring boards for African clinical trials. Trans. R. Soc. Trop. Med. Hyg. 102 12 (2008) 1189-1194 Epub 2008, Jul 21
28. Lavery, James V., Harrington L.C., and Scott T.W. Ethical, social, and cultural considerations for site selection for research with genetically modified mosquitoes. Am. J. Trop. Med. Hyg. 79 3 (2008) 312-318
29. Louis, C., Knols, B.G.J., 2006. Report of the Working Group Meeting. Bridging Laboratory and Field Research for Genetic Control of Disease Vectors. http://library.wur.nl/ojs/index.php/frontis/issue/view/230. Accessed on 27th July 2009.
30. Macer D. Ethical Legal and Social Issues of Genetically Modified Disease Vectors in Public Health, Geneva (2003), WHO/TDR
31. Mboera L.E.G. Sampling techniques for adult Afrotropical malaria vectors and their reliability in the estimation of entomological inoculation rate. Tanzania Health Res. Bull. 7 3 (2005) 117-124
32. Mshinda H., Killeen G.F., Mukabana W.R., et al. Development of genetically modified mosquitoes in Africa. Lancet Infect. Diseases 4 (2004) 264-265. http://infection.thelancet.com/ http://infection.thelancet.com
33. Mutabingwa T.K., Hills E., and Kilama W.L. Response of Plasmodium falciparum to chloroquine in hospital patients in Muheza, Tanzania. East Afr. Med. J. 62 (1985) 161-171
34. National Bioethics Advisory Commission. Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries (2001), NBAC, Bethesda, MD, USA
35. Nuffield Council on Bioethics. Public Health Ethics: Ethical Issues (2007), Nuffield Council on Bioethics, London 191 pp.
36. Nyika A., Kilama W., Chilengi R., Tangwa G., Tindana P., Ndebele P., and Ikingura J. Composition, training needs and independence of ethics review committees across Africa: are the gate-keepers rising to the emerging challenges?. J. Med. Ethics 35 (2009) 189-193
37. Public Health Leadership Society. Principles of the Ethical Practice of Public Health. Version 2.2 (2002), Public Health Leadership Society. http://www.phls.org/ Available at: www.phls.org. Accessed on 31 July 2009
38. Read A.F., Lynch A., and Thomas M.B. How to make evolution-proof insecticides for malaria control. PLoS Biol. 7 4 (2009) e1000058 10.1371/journal.pbio.1000058
39. Roberts D.R., Laughlin L.L., Hsheih P., and Legters L. DDT, global strategies and a malaria control crisis in South America. Emerg. Infect. Dis. 3 (1997) 295-302
40. Roberts D.R., Manguin S., and Mouchet J. DDT house spraying and re-emerging malaria. Lancet 356 (2000) 330-332
41. Schmied W.H., Takken W., Killeen G.F., et al. Evaluation of two counterflow traps for testing behaviour-mediating compounds for the malaria vector Anopheles gambiae s.s. under semi-field conditions in Tanzania. Malaria J. 7 (2008) 230
42. Scholte E.J., Ng'habi K., Kihonda J., et al. Entomolpathogenic fungus for control of adult African malaria mosquitoes. Science 308 (2005) 1641-1642
43. South Africa, (2004). Guidelines on Ethics for Medical Research: general principles. Medical Research Council (South Africa).
44. Stockholm Convention on Persistent Organic Pollutants, 2001. Available at: http://chm.pops.int/Portals/0/Repository/convention. Accessed on 17 June 2009.
45. Takken W., and Knols B.G.J. Odor-mediated behavior of Afrotropical malaria mosquitoes. Annu. Rev. Entomol. 44 (1999) 131-157
46. Tindana P.O., Singh J.A., Shawn T.C., et al. Grand challenges in global health: community engagement in research in developing countries. PLoS Med. 4 9 (2007). www.plosmedicine.org
47. Toure Y.T., and Knols B.G.J. Genetically-modified mosquitoes for malaria control: requirements to be considered before field releases. In: Christophe Boete (Ed). Genetically Modified Mosquites for Malaria Control (2005), Eurekah.com
48. World Health Organisation. WHO-supported collaborative research projects in India: the facts. WHO Chron. 30 (1976) 131-139
49. World Health Organization, 2006. WHO Gives Indoor Use of DDT a Clean Bill of Health for Controlling Malaria. Available at: http://www.who.int/mediacentre/news/releases/2006/pr50/en. Accessed on 31 July 2009.
50. World Health Organization. Bull. World Health Org. 86 8 (2008) 577-656
51. World Health Organization, 2008b. World Malaria Report 2008. Geneva, 50 pp.
52. World Medical Association Declaration of Helsinki. Available at http://www.wma.net/e/policy/17-c_e.html. Accessed on 31 July 2009. Ethical Principles for Medical Research Involving Human Subjects. 52nd WMA General Assembly. Edinburgh, Scotland (2000)